RxDoctor Payments Data

Janet Turkle

Plastic and Reconstructive Surgery · Carmel, INNPI 1093750713

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (48.2%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. AbbVie accounts for 84.8% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $6,052 and has fallen 86.0% since, to $845 in 2025. Among plastic and reconstructive surgery clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$15,253in general payments, 2019–2025

Across 444 payments — averaging $34.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$13K
  • Merz North America, Inc.$1K
  • Revance Therapeutics, Inc.$544
  • Boston Scientific$162
  • Motiva USA, LLC$140
  • Hologic Sales And Service, LLC$40
  • plus $96 from 5 others
$4,350in research payments, 2019–2025

Across 2 payments — averaging $2175.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$4K

What the payments were for

  • Consulting fees$3,36422%
  • Speaking & faculty fees$4,50030%
  • Food & beverage$7,35548%
  • Education$340%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,253 in reported general payments places this provider in the 95th percentile of 47 plastic and reconstructive surgery providers in Indiana.

See all plastic and reconstructive surgery providers in Indiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin15$168
Oxycodone Hcl18$92
Ondansetron OdtOndansetron26$52
Gabapentin24$35
Acyclovir18$27

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Carmel

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →